Husch Blackwell's False Claims Act Insights podcast explores how the U.S. government uses the False Claims Act to stamp out fraud and corruption in government contracts.
Host Jonathan Porter welcomes Husch Blackwell senior counsel Robert Hess to discuss a groundbreaking Ninth Circuit decision that expands False Claims Act exposure in the 340B drug pricing program. With the Adventist Health case challenging long-held assumptions about FCA liability in the 340B context, Rob provides essential guidance for manufacturers, covered entities, contract pharmacies, and payors navigating this evolving risk landscape.